NCT07541352 2026-04-22
HRCC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not yet recruiting
Clinical Trials
288 trialsNCT07544589 2026-04-22
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Dispatch Biotherapeutics
Phase 1 Not yet recruiting
NCT07545122 2026-04-22
CT-202
Context Therapeutics Inc.
Phase 1 Not yet recruiting
NCT07545356 2026-04-22
A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Phase 1 Not yet recruiting
NCT07542704 2026-04-21
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Kumquat Biosciences Inc.
Phase 1 Not yet recruiting
NCT06655142 2026-04-17
OSCAR II STUDY - The ONCObind CTC Removal Study
ExThera Medical Corporation
Phase NA Not yet recruiting
NCT07535632 2026-04-17
BEST
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT07225309 2026-04-14
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Not yet recruiting
NCT07436637 2026-04-14
Guardant Shield Colorectal Cancer Screening
University of Miami
Phase NA Not yet recruiting
NCT07527832 2026-04-14
An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.
Pfizer
Not yet recruiting
NCT07523035 2026-04-13
Colorectal Adenoma Cohort
Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
NCT07525206 2026-04-13
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
AbbVie
Phase 3 Not yet recruiting
NCT07128355 2026-04-09
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Massachusetts General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07211230 2026-04-09
Collagenase Biobank Study
University of Chicago
Not yet recruiting
NCT07519681 2026-04-09
Effects of Berberine on the Human Gut Microbiome
Shanghai Jiao Tong University School of Medicine
Phase NA Not yet recruiting
NCT07515729 2026-04-07
Raising Awareness of Colorectal Screening in American Indian Communities
University of Oklahoma
Not yet recruiting
NCT07515820 2026-04-07
SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study
West China Hospital
Phase 2 Not yet recruiting
NCT07515963 2026-04-07
FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.
Zhongnan Hospital
Phase 2 Not yet recruiting
NCT07496528 2026-04-06
ACURE
Chang Gung Memorial Hospital
Phase NA Not yet recruiting
NCT07497789 2026-04-06
AIRC_ IG 34634
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Not yet recruiting
NCT07509398 2026-04-03
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer
Shanghai 10th People's Hospital
Phase 2/3 Not yet recruiting
NCT07468071 2026-04-02
KontRASt-R
Novartis
Phase 1/2 Not yet recruiting
NCT07502963 2026-03-31
PREDU
University of Vic - Central University of Catalonia
Phase NA Not yet recruiting
NCT07503756 2026-03-31
JS212 Combination Therapies in Metastatic Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
NCT07504263 2026-03-31
Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies
Recurv Pharma Inc
Phase 1/2 Not yet recruiting
NCT06971848 2026-03-30
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT07500259 2026-03-30
COLOPan
Luxembourg Institute of Health
Not yet recruiting
NCT07500298 2026-03-30
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT07502014 2026-03-30
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer
Huazhong University of Science and Technology
Phase 2 Not yet recruiting
NCT07489833 2026-03-27
Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue
Chang Gung Memorial Hospital
Not yet recruiting
NCT07487168 2026-03-23
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Not yet recruiting
NCT07089771 2026-03-20
Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy
Region Stockholm
Phase NA Not yet recruiting
NCT07281768 2026-03-20
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Not yet recruiting
NCT06258525 2026-03-18
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Cedars-Sinai Medical Center
Phase 2 Not yet recruiting
NCT07474025 2026-03-16
Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritoneal Metastses
Jules Bordet Institute
Not yet recruiting
NCT07474727 2026-03-16
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Multitude Therapeutics Inc.
Phase 2 Not yet recruiting
NCT07296887 2026-03-12
CARE Tool Study Aim 3
Washington University School of Medicine
Phase NA Not yet recruiting
NCT07411599 2026-03-12
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
M.D. Anderson Cancer Center
Phase 1/2 Not yet recruiting
NCT07467590 2026-03-12
TRIUNITE-07
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Not yet recruiting
NCT07435038 2026-03-11
Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Betta Pharmaceuticals Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07463690 2026-03-11
Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
Sun Yat-sen University
Phase NA Not yet recruiting
NCT07464769 2026-03-11
KompXX
Region Jönköping County
Phase NA Not yet recruiting
NCT07453797 2026-03-06
VISION
Activ Surgical
Phase NA Not yet recruiting
NCT07453875 2026-03-06
TRIUNITE06
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 1 Not yet recruiting
NCT07446387 2026-03-03
A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Not yet recruiting
NCT07446465 2026-03-03
FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal Cancer
Fudan University
Phase 4 Not yet recruiting
NCT07277322 2026-03-02
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Icahn School of Medicine at Mount Sinai
Phase 1/2 Not yet recruiting
NCT07162337 2026-02-27
BILMOD
Massachusetts General Hospital
Phase NA Not yet recruiting
NCT07318389 2026-02-27
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07417488 2026-02-27
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
Thomas Jefferson University
Phase 1 Not yet recruiting